NeoStem’s (AMEX: NBS) Progenitor Cell Therapy (PCT) adds to Management to meet Demand
October 19th, 2011
No comments
Industry veterans join PCT to assist client-focused development, manufacturing and growing portfolio of cellular therapeutic candidates. Read more…
